Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate.

Ítems similars

• Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis
  per: Sharma, S, et al.
  Publicat: (1999)
• Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects
  per: Khan, F, et al.
  Publicat: (2003)
• Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease
  per: Dobson, L S, et al.
  Publicat: (2000)
• Angiolymphoid hyperplasia with eosinophilia treated with low-dose methotrexate
  per: Alaidarous, Abdulqader, et al.
  Publicat: (2015)
• Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?
  per: Gillespie, A M, et al.
  Publicat: (1999)